Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Søren Dinesen Østergaard, Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT01518049
First received: January 21, 2012
Last updated: July 18, 2013
Last verified: July 2013

January 21, 2012
July 18, 2013
February 2012
September 2013   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01518049 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)
Not Provided

The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression.

Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

blood samples

Non-Probability Sample

inpatients or outpatients at Danish Psychiatric Hospitals fulfilling criteria for unipolar depression with psychotic symptoms.

Affective Disorders, Psychotic
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
50
September 2014
September 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Fulfilling ICD-10 criteria DF32.3 or DF33.3
  • At least 18 years old
  • Legally competent
  • Informed consent (oral & written)

Exclusion Criteria:

  • Insufficient Danish Language skills
  • Moderate to severe dementia
  • Abuse of psychoactive substances
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT01518049
N-20110029
No
Søren Dinesen Østergaard, Aarhus University Hospital
Søren Dinesen Østergaard
Not Provided
Principal Investigator: Søren D Østergaard, MD Aahus University Hospital
Aarhus University Hospital
July 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP